JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SPIEGEL, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SPIEGEL, E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 63, Issue 4, 438-442, 1938
Copyright © 1938 by American Society for Pharmacology and Experimental Therapeutics

BULBOCAPNINE-BENZEDRINE ANTAGONISM

E. SPIEGEL 1

1 From the Department of Experimental Neurology, D. J. McCarthy Foundation, Temple University School of Medicine, Philadelphia, Pennsylvania

The state of catalepsy produced by injection of bulbocapnine may be abolished by administration of benzedrine, and the hyperkinesis typical for the effect of this latter toxin may develop despite the preceding bulbocapnine catalepsy. The benzedrine hyperkinesis is only slightly diminished by a succeeding bulbocapnine injection.

Submitted on March 7, 1938






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1938 by the American Society for Pharmacology and Experimental Therapeutics.